Abstract:BACKGROUND:Tumorigenesis, metastasis, and treatment response of hepatocellular carcinoma (HCC) are regulated by unfolded protein responses (UPR) signaling pathways, including IRE1a, PERK, and ATF6, but little is known about UPR related genes with HCC prognosis and therapeutic indicators.OBJECTIVE:We aimed to identify a UPR related prognostic signature (UPRRPS) for HCC and explore the potential effect of the current signature on the existing molecular targeted agents and immune checkpoint inhibitors (ICIs).METHODS:We used The Cancer Genome Atlas (TCGA) database to screen candidate UPR genes (UPRGs), which are expressed differentially between hepatocellular carcinoma and normal liver tissue and associated with prognosis. A gene risk score for overall survival prediction was established using the least absolute shrinkage and selection operator (LASSO) regression analysis, which was validated using data from the International Cancer Genome Consortium (ICGC) database and evaluated by the C-index. Then immune and molecular characteristics stratified by the current UPRRPS were analyzed, and the corresponding drug sensitivity was conducted.RESULTS:Initially, 42 UPRGs from the TCGA database were screened as differentially expressed genes, which were also associated with HCC prognosis. Using the LASSO regression analysis, nine UPRGs (EXTL3, PPP2R5B, ZBTB17, EIF2S2, EIF2S3, HDGF, SRPRB, EXTL2, and TPP1) were used to develop a UPRRPS to predict the OS of HCC patients in the TCGA set with the Cindex of 0.763. The current UPRRPS was also well-validated in the ICGC set with the C-index of 0.700. Multivariate Cox regression analyses also confirmed that the risk score was an independent risk factor for HCC in both the TCGA and ICGC sets (both P<0.05). Functional analyses showed that low-risk score was associated with increased natural killer cells, T helpers, tumor immune dysfunction and exclusion score, microsatellite instability expression, and more benefit from ICIs; the high-risk score was associated with increased active dendritic cells, Tregs, T-cell exclusion score, and less benefit from ICIs. Gene set enrichment analyses showed that the signaling pathways of VEGF, MAPK, and mTOR were enriched in high UPRRPS, and the drug sensitivities of the corresponding inhibitors were all significantly higher in the high UPRRPS subgroup (all P<0.001).CONCLUSION:With the current findings, UPRRPS was a promising biomarker for predicting the prognosis of HCC patients. UPRRPS might also be taken as a potential indicator to guide the management of immune checkpoint inhibitors and molecular targeted agents.

Upregulator Of Cell Proliferation Predicts Poor Prognosis In Hepatocellular Carcinoma And Contributes To Hepatocarcinogenesis By Downregulating Foxo3a

Up-regulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma]

URG4/URGCP Enhances the Angiogenic Capacity of Human Hepatocellular Carcinoma Cells in Vitro Via Activation of the NF-κB Signaling Pathway

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer

URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma

An Unfolded Protein Response-Related Mrna Signature Predicting the Survival and Therapeutic Effect of Hepatocellular Carcinoma.

326 SPECIAL AT-RICH SEQUENCES BINDING PROTEIN1 UPREGULATES MATRIX METALLOPROTEINASE-9 AND INDUCES HUMAN HEPATOCELLULAR CARCINOMA INVASION

Prognostic Role of Unfolded Protein Response-Related Genes in Hepatocellular Carcinoma.

Long Noncoding RNA FOXP4-AS1 Predicts Unfavourable Prognosis and Regulates Proliferation and Invasion in Hepatocellular Carcinoma

Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma

Unveiling the role of UPF3B in hepatocellular carcinoma: Potential therapeutic target

Long Non-coding RNA URHC Regulates Cell Proliferation and Apoptosis Via ZAK Through the ERK/MAPK Signaling Pathway in Hepatocellular Carcinoma

Upregulated Expression of Ubiquitin-Conjugating Enzyme E2Q1 (UBE2Q1) is Associated with Enhanced Cell Proliferation and Poor Prognosis in Human Hapatocellular Carcinoma

Upregulation Of Uhrf1 Promotes Renal Cancer Metastasis And Poor Prognosis

UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway

Enhanced Cell Survival of Gastric Cancer Cells by a Novel Gene URG4

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3

Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2

Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.